Company Profile
PharmaVision was created by Dr Cheryl Lee Barton in 2002 to provide independent, tailor made pharmaceutical thematic research to investment houses, competitive intelligence specialists and pharmaceutical companies. The research reports combine independent scientific analysis with market models to forecast the potential growth of key developmental products and technologies.
Pharmavision was formed in order to write and publish independent and impartial analysis of the pharmaceutical industry with a focus on drug delivery, it’s players, their products and the issues surrounding this specialist sector. Using PharmaVision's market modeling and analysis insight, we aim to deliver market analysis papers of quality and value to its readers.
Latest Papers
 Antibiotics and Drug Resistance 2008Drug Innovation and the Strategy to Combat Antibiotic Resistance Mechanisms This report reviews new drug innovation and strategy to combat antibiotic resistance mechanisms. This embraces current research-stage activities, patents published in the last five years, the entire pharmaceutical development pipeline and today's exi... Price: £1,499.00 Author: Dr John Bates / Date Published: 01 August 2008 |
|
Cancer Stem Cells Emerging Therapeutic, Diagnostic and Market Opportunities Tumours and haematological cancers contain small populations of cells that are believed to play a critical role in the development and progression of the disease. These cells, named Cancer Stem Cells (CSCs), have been found in leukaemia, myeloma, bre... Price: £1,599.00 Author: Dr John Bates / Date Published: 20 June 2008 |
|
The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends Introduction: Diagnostics can be used to identify subgroups of patients who may or may not benefit from a companion drug, who may have adverse reactions to that drug, or who may require different doses of that drug because of their particular meta... Price: £0.00 Author: Cheryl Barton, Ph.D. / Date Published: 01 June 2008 |
